What to know
- CDC’s Division of Overdose Prevention is hosting a webinar on the clinical and public health implications of medetomidine-involved opioid overdose and withdrawal.
- Webinar date and time: August 7, 2025. 11am EDT.
CDC Webinar: Clinical Implications of Medetomidine Mixed with Opioids
Learn lessons from the field about the diagnosis and treatment of overdoses and withdrawal involving medetomidine mixed with opioids. CDC's Division of Overdose Prevention is hosting a webinar on the clinical and public health implications of medetomidine-involved opioid overdose and withdrawal.
This is an emerging public health problem, and clinicians and public health agencies need to be aware of how shifts in the drug supply over time, such as the addition of adulterants like medetomidine, might change patient signs, symptoms, and management during opioid overdose or withdrawal. Continuing education (CME and CNE) is available.
Join the Webinar at https://youtube.com/live/QuOHI3F4R0I?feature=share
Date: August 7, 2025
Time: 11am EDT
Speakers:
Allison Arwady, MD, MPH, Director, National Center for Injury Prevention and Control, CDC
Ann M. Sheehy, MD, MS, Chief Medical Officer and Director, Office of Planning, Analysis and Evaluation, Health Resources and Services Administration (HRSA)
Samantha Huo, MD, University of Pennsylvania
Jeanmarie Perrone, MD, University of Pennsylvania